Navigation Links
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Date:10/8/2008

the TAXUS Element Stent System incorporates new balloon technology, intended to improve on Boston Scientific's market-leading Maverick(R) Balloon Catheter platform.

"The new alloy and stent design of TAXUS Element provides improved deliverability and visibility, even in patients with complex and challenging anatomy," said Dean J. Kereiakes, M.D., Medical Director at The Christ Hospital Heart and Vascular Center and The Lindner Research Center in Cincinnati and the principal investigator for the trials. "I am very enthusiastic about the potential the TAXUS Element Stent offers me to treat a broader range of patients."

The TAXUS PERSEUS clinical program will evaluate the efficacy and safety of the TAXUS Element Stent in two studies.

The first study, TAXUS PERSEUS Workhorse (A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions), will evaluate the safety and efficacy of the TAXUS Element Stent compared to Boston Scientific's first generation drug-eluting stent, the TAXUS(R) Express(TM) Stent. This 3:1 randomized study will evaluate 1,264 patients from 94 sites in the U.S., Australia, New Zealand and Singapore with "workhorse" lesions from 2.75 to 4.0 millimeters in diameter. The primary endpoint of the workhorse study is target lesion failure (TLF) at 12 months, and its secondary endpoint is in-segment percent diameter stenosis at nine months.

A second parallel study named the TAXUS PERSEUS Small Vessel study will compare the TAXUS Element Stent to a historic control (TAXUS V de novo bare-metal Express(R) Coronary Stent System). This study will include 224 patients from 35 U.S. sites with lesions from 2.25 up to 2.75 millimeters. The primary endpoint of the small vessel study is in-stent late loss at nine months, and its secondary endpoint is TLF at 12 months.

The TAXUS Element Stent is an
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
2. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
4. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
5. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
6. Leading Immunologists Convene in Boston
7. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
8. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
9. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , June 25, 2015 ... of the "Veterinary / Animal Vaccines Market by ... report to their offering. The global ... by 2020 from $5,507.3 Million in 2015, at a ... Major factors fueling market growth are growing prevalence of ...
(Date:7/2/2015)... Agreement reinforces ...   ViiV Healthcare and Desano Pharmaceuticals (Desano) ... China of dolutegravir. The agreement will ... (API), and will allow ViiV Healthcare to offer a competitive ... name Tivicay®) for China and a ...
(Date:7/1/2015)... Colo. , July 1, 2015   ... in implantable hearing solutions, announced today the US ... Cochlear™ Nucleus® Profile™ Implant with Slim Straight Electrode ... and developed in close collaboration with the world,s ... cochlear implant platform designed to provide the most ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3
... Inc. (Nasdaq: MYL ) today announced that its ... Food and Drug Administration (FDA) for its Abbreviated New Drug ... and 500 mg Single-use Vials. This product is the generic ... a chemoprotective agent. Dexrazoxane for Injection, when indicated ...
... Nov. 28, 2011 Gaylord Sleep Medicine now offers ... Glastonbury, Guilford, North Haven and Trumbull locations. ... Sleep Apnea Management program has expanded to offer PAP ... needs. Originally designed to improve PAP compliance, the program ...
Cached Medicine Technology:Gaylord Sleep Medicine Expands Sleep Apnea Management Program 2
(Date:7/2/2015)... Pennsylvania (PRWEB) , ... July ... ... largest e-commerce janitorial supply company , announced today that it has ... Products. The acquisition will make CleanItSupply.com the largest distributor of Rubbermaid Commercial ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies ... pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation ... on the conservative treatment of back, hip, knee and shoulder pain as well ...
(Date:7/2/2015)... ... July 02, 2015 , ... Five ... Preparedness (CDP) in Anniston for specialized disaster training. The team – composed of ... the Southern California Hospital Association who attended the training, which is dedicated to ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/2/2015)... AR (PRWEB) , ... July 02, 2015 , ... Throughout ... families through their annual “Dog Tag” campaign. On Tuesday, July 7, Casey’s General ... Warriors® for nearly $800,000. Hope For The Warriors® is a national nonprofit dedicated to ...
Breaking Medicine News(10 mins):Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3
... of effectiveness over time , , MONDAY, May 12 (HealthDay News) ... legs syndrome do provide relief, but they are burdened by ... many sufferers to stop taking them, a new analysis finds. ... can,t fully explain is that they have more robust effects ...
... baby boomers say,they are financially unprepared for a ... Harris Interactive on behalf of America,s Health,Insurance Plans ... and,many would have to tap into their retirement ... ), "Baby boomers have too much ...
... assessments worldwide verify safety and quality of technically ... advanced zirconium oxide material., ... provider of,ceramic solutions for the medical device industry, has submitted ... (FDA) for,its new technical ceramic dental component, ZirDent(TM) CAD/CAM Blocks.,ZirDent(TM) ...
... CHENGDU, China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., ... of modernized traditional Chinese medicine ("TCM") based in,Chengdu, ... at Roth Third,Annual China Discovery Tour on Tuesday, ... Conference will be held at the Regent Hotel ...
... trial in bladder cancer exceeds 2/3rds enrolment level ... pre-clinical work in peritoneal cancers -, BELLEVILLE, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, is ... non-clinical development of its proprietary platform technology:,Mycobacterial Cell ...
... Re-implantation of devices at shorter distances improved motor scores, ... A few millimeters can make a huge difference for ... brain, a new study finds. , Implanting electrodes ... brain potentially related to impulsivity, has helped people with ...
Cached Medicine News:Health News:Drugs for Restless Legs Syndrome Have Downsides 2Health News:Drugs for Restless Legs Syndrome Have Downsides 3Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 3Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 4Health News:Electrode Placement Key to Brain Stimulation for Parkinson's Patients 2
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Used for complex diagnostic and interventional procedures....
The Emerald Guidewire is intended for percutaneous introduction of catheters....
... Medical offers a complete line ... with percutaneous catheter introducers to ... catheters. Our diagnostic guidewires are ... incorporate a proprietary surface finish ...
Medicine Products: